Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome

被引:31
|
作者
Thanakun, Supanee [1 ,2 ]
Watanabe, Hisashi [3 ]
Thaweboon, Sroisiri [4 ]
Izumi, Yuichi [3 ,5 ]
机构
[1] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10400, Thailand
[2] Mahidol Univ, Dent Ctr, Golden Jubilee Med Ctr, Bangkok 10400, Thailand
[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan
[4] Mahidol Univ, Fac Dent, Dept Oral Microbiol, Bangkok 10400, Thailand
[5] Tokyo Med & Dent Univ, Global Ctr Excellence Program Tooth & Bone Res, Bangkok, Japan
来源
关键词
Saliva; Plasma; Adiponectin; Leptin; Metabolic syndrome; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; SERUM ADIPONECTIN; PREVALENCE; ASSOCIATION;
D O I
10.1186/1758-5996-6-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS. Methods: Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA). Results: Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002-1.015 and OR = 1.125; 95% CI 1.029-1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212-2.168 and OR = .966; 95% CI .938-.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977). Conclusions: This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
    Supanee Thanakun
    Hisashi Watanabe
    Sroisiri Thaweboon
    Yuichi Izumi
    Diabetology & Metabolic Syndrome, 6
  • [2] Leptin and adiponectin plasma concentrations in patients with metabolic syndrome
    Pucilowska, B
    Paschalis-Purtak, K
    Janas, J
    Makowiecka-Ciesla, M
    Prejbisz, A
    Hoffman, P
    Januszewicz, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S337 - S337
  • [3] The influence of atorvastatin therapy on plasma concentrations of adiponectin, resistin and leptin in patients with metabolic syndrome
    Szotowska, M.
    Czerwienska, B.
    Adamczak, M.
    Chudek, J.
    Wiecek, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 7 - 7
  • [4] Comparison between adiponectin and leptin regarding their relationship to metabolic syndrome
    Matsushita, Kunihiro
    Yatsuya, Hiroshi
    Tamakoshi, Koji
    Mitsuhashi, Hirotsugu
    Sugiura, Kaichiro
    Kondo, Takahisa
    Murohara, Toyoaki
    Toyoshima, Hideaki
    CIRCULATION, 2006, 114 (18) : 861 - 861
  • [5] THE INFLUENCE OF ATORVASTATIN THERAPY ON PLASMA CONCENTRATIONS OF ADIPONECTIN, RESISTIN AND LEPTIN IN PATIENTS WITH METABOLIC SYNDROME
    Szotowska, M.
    Czerwienska, B.
    Adamczak, M.
    Chudek, J.
    Wiecek, A.
    HYPERTENSION, 2010, 56 (06) : 1179 - 1179
  • [6] Leptin-to-adiponectin Ratio in Patients with Psoriasis and Metabolic Syndrome
    Diaconu, Laura Florina
    Timar, Romulus Zorin
    Serban, Viorel
    Timar, Romulus Bogdan
    Feier, Virgil
    Timar, Mariana
    OBESITY, 2009, 17 : S107 - S107
  • [7] Leptin and adiponectin in patients with venous thromboembolism and metabolic syndrome.
    Ay, Leyla
    Ay, Cihan
    Bieglmayer, Christian
    Koder, Silvia
    Wagner, Oswald
    Schernthaner, Guntram
    Pabinger, Ingrid
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 : S3 - S3
  • [8] Comparison between adiponectin and leptin in relation to metabolic syndrome in Japanese women
    Matsushita, Kunihiro
    Yatsuya, Hiroshi
    Tamakoshi, Koji
    Mitsuhashi, Hirotsugu
    Kondo, Takahisa
    Murohara, Toyoaki
    Toyoshima, Hideaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E84 - E84
  • [9] Comparison of adiponectin, leptin and, leptin to adiponectin ratio as, diagnostic marker for metabolic syndrome in older adults of Chinese major cities
    Zhuo, Qin
    Wang, Zhiqiang
    Fu, Ping
    Piao, Jianhua
    Tian, Yuan
    Xu, Jie
    Yang, Xiaoguang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 84 (01) : 27 - 33
  • [10] Expression of Leptin, NGF and Adiponectin in Metabolic Syndrome
    Atanassova, Pepa
    Hrischev, Peter
    Orbetzova, Maria
    Nikolov, Peter
    Nikolova, Julia
    Georgieva, Elenka
    FOLIA BIOLOGICA-KRAKOW, 2014, 62 (04): : 301 - 306